Participants 439 771 8
ROCAS study is a randomized, double-blind, placebo-controlled study evaluating the effects of simvastatin 20 mg daily upon progression of asymptomatic middle cerebral artery stenosis among stroke-free individuals over 2 years. A total of 227 subjects were randomized to either placebo (n = 114) or simvastatin 20 mg daily (n = 113).
Participants 972 1038 3
Among the 227 randomized subjects, 33 (14.5%) had SBI at baseline.
